{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:41:47Z","timestamp":1761964907483},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12026-017-8934-y","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T06:28:15Z","timestamp":1500013695000},"page":"944-950","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["IgG4-related disease involving polyserous effusions with elevated serum interleukin-6 levels: a case report and literature review"],"prefix":"10.1007","volume":"65","author":[{"given":"Xiang","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panwen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"1","key":"8934_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1\u201314. doi: 10.1007\/s10165-011-0508-6 .","journal-title":"Mod Rheumatol"},{"issue":"2","key":"8934_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.autrev.2016.12.008","volume":"16","author":"F Martinez-Valle","year":"2017","unstructured":"Martinez-Valle F, Fernandez-Codina A, Pinal-Fernandez I, Orozco-Galvez O, Vilardell-Tarres M. IgG4-related disease: evidence from six recent cohorts. Autoimmun Rev. 2017;16(2):168\u201372. doi: 10.1016\/j.autrev.2016.12.008 .","journal-title":"Autoimmun Rev"},{"issue":"4","key":"8934_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/01.pas.0000213445.08902.11","volume":"31","author":"W Cheuk","year":"2007","unstructured":"Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease? Am J Surg Pathol. 2007;31(4):643\u20135. doi: 10.1097\/01.pas.0000213445.08902.11 .","journal-title":"Am J Surg Pathol"},{"key":"8934_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","volume":"9","author":"VS Mahajan","year":"2014","unstructured":"Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol. 2014;9:315\u201347. doi: 10.1146\/annurev-pathol-012513-104708 .","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"8934_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/annrheumdis-2014-206405","volume":"74","author":"EL Culver","year":"2015","unstructured":"Culver EL, Vermeulen E, Makuch M, van Leeuwen A, Sadler R, Cargill T, et al. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Ann Rheum Dis. 2015;74(5):944\u20137. doi: 10.1136\/annrheumdis-2014-206405 .","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8934_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000658-195803000-00018","volume":"147","author":"K Inada","year":"1958","unstructured":"Inada K, Hamazaki M. Localized mediastinal lymph-node hyperplasia resembling thymoma; a case report. Ann Surg. 1958;147(3):409\u201313.","journal-title":"Ann Surg"},{"issue":"12","key":"8934_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/jcp.2010.082958","volume":"63","author":"Y Sato","year":"2010","unstructured":"Sato Y, Kojima M, Takata K, Morito T, Mizobuchi K, Tanaka T, et al. Multicentric Castleman\u2019s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010;63(12):1084\u20139. doi: 10.1136\/jcp.2010.082958 .","journal-title":"J Clin Pathol"},{"issue":"11","key":"8934_CR8","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.7759\/cureus.380","volume":"7","author":"CE Cervantes","year":"2015","unstructured":"Cervantes CE, Correa R. Castleman disease: a rare condition with endocrine manifestations. Cureus. 2015;7(11):e380. doi: 10.7759\/cureus.380 .","journal-title":"Cureus"},{"issue":"17","key":"8934_CR9","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","volume":"118","author":"A D\u2019Souza","year":"2011","unstructured":"D\u2019Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011;118(17):4663\u20135. doi: 10.1182\/blood-2011-06-362392 .","journal-title":"Blood"},{"issue":"6","key":"8934_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00408-013-9497-x","volume":"191","author":"T Ogoshi","year":"2013","unstructured":"Ogoshi T, Kido T, Yatera K, Oda K, Kawanami T, Ishimoto H, et al. Assessment of pathologically diagnosed patients with Castleman\u2019s disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung. 2013;191(6):575\u201383. doi: 10.1007\/s00408-013-9497-x .","journal-title":"Lung"},{"issue":"4","key":"8934_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/107327481402100403","volume":"21","author":"JD Soumerai","year":"2014","unstructured":"Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control. 2014;21(4):266\u201378.","journal-title":"Cancer Control"},{"issue":"1","key":"8934_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21\u201330. doi: 10.1007\/s10165-011-0571-z .","journal-title":"Mod Rheumatol"},{"issue":"9","key":"8934_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392. doi: 10.1038\/modpathol.2012.72 .","journal-title":"Mod Pathol"},{"issue":"1","key":"8934_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jhbp.50","volume":"21","author":"A Tanaka","year":"2014","unstructured":"Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2014;21(1):43\u201350. doi: 10.1002\/jhbp.50 .","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"8934_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539\u201351. doi: 10.1056\/NEJMra1104650 .","journal-title":"N Engl J Med"},{"issue":"1","key":"8934_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/BOR.0b013e3283413469","volume":"23","author":"RP Sah","year":"2011","unstructured":"Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol. 2011;23(1):108\u201313. doi: 10.1097\/BOR.0b013e3283413469 .","journal-title":"Curr Opin Rheumatol"},{"issue":"15","key":"8934_CR17","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1097\/md.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680. doi: 10.1097\/md.0000000000000680 .","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"8934_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14\u20138. doi: 10.1136\/annrheumdis-2013-204907 .","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"8934_CR19","doi-asserted-by":"publisher","first-page":"e3785","DOI":"10.1097\/md.0000000000003785","volume":"95","author":"M Hao","year":"2016","unstructured":"Hao M, Liu M, Fan G, Yang X, Li J. Diagnostic value of serum IgG4 for IgG4-related disease: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95(21):e3785. doi: 10.1097\/md.0000000000003785 .","journal-title":"Medicine (Baltimore)"},{"key":"8934_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/tcrm.s99985","volume":"12","author":"D Lang","year":"2016","unstructured":"Lang D, Zwerina J, Pieringer H. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag. 2016;12:189\u201399. doi: 10.2147\/tcrm.s99985 .","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"8934_CR21","doi-asserted-by":"publisher","first-page":"e0124233","DOI":"10.1371\/journal.pone.0124233","volume":"10","author":"Y Su","year":"2015","unstructured":"Su Y, Sun W, Wang C, Wu X, Miao Y, Xiong H, et al. Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders. PLoS One. 2015;10(4):e0124233. doi: 10.1371\/journal.pone.0124233 .","journal-title":"PLoS One"},{"issue":"41","key":"8934_CR22","doi-asserted-by":"publisher","first-page":"e1707","DOI":"10.1097\/md.0000000000001707","volume":"94","author":"KH Yu","year":"2015","unstructured":"Yu KH, Chan TM, Tsai PH, Chen CH, Chang PY. Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease. Medicine (Baltimore). 2015;94(41):e1707. doi: 10.1097\/md.0000000000001707 .","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"8934_CR23","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen Y, Inoue D, Kitao A, Onodera M, Abo H, Miyayama S, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2009;33(12):1886\u201393. doi: 10.1097\/PAS.0b013e3181bd535b .","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"8934_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/resp.12016","volume":"18","author":"S Matsui","year":"2013","unstructured":"Matsui S, Hebisawa A, Sakai F, Yamamoto H, Terasaki Y, Kurihara Y, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology. 2013;18(3):480\u20137. doi: 10.1111\/resp.12016 .","journal-title":"Respirology"},{"issue":"1","key":"8934_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1148\/radiol.2511080965","volume":"251","author":"D Inoue","year":"2009","unstructured":"Inoue D, Zen Y, Abo H, Gabata T, Demachi H, Kobayashi T, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology. 2009;251(1):260\u201370. doi: 10.1148\/radiol.2511080965 .","journal-title":"Radiology"},{"issue":"8","key":"8934_CR26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2169\/internalmedicine.50.4726","volume":"50","author":"H Yamamoto","year":"2011","unstructured":"Yamamoto H, Suzuki T, Yasuo M, Kobayashi O, Tsushima K, Ito M, et al. IgG4-related pleural disease diagnosed by a re-evaluation of chronic bilateral pleuritis in a patient who experienced occasional acute left bacterial pleuritis. Intern Med. 2011;50(8):893\u20137.","journal-title":"Intern Med"},{"issue":"7","key":"8934_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00296-016-3501-8","volume":"36","author":"J Gonzalez-Moreno","year":"2016","unstructured":"Gonzalez-Moreno J, Losada-Lopez I, Gallego-Lezaun C, Garcia-Gasalla M, Gomez Bellvert C, Ortego CN. Serosal involvement in IgG4-related disease: report of two cases and review of the literature. Rheumatol Int. 2016;36(7):1033\u201341. doi: 10.1007\/s00296-016-3501-8 .","journal-title":"Rheumatol Int"},{"issue":"3","key":"8934_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/jcp.2010.085613","volume":"64","author":"JD Strehl","year":"2011","unstructured":"Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64(3):237\u201343. doi: 10.1136\/jcp.2010.085613 .","journal-title":"J Clin Pathol"},{"key":"8934_CR29","doi-asserted-by":"publisher","unstructured":"Terasaki Y, Ikushima S, Matsui S, Hebisawa A, Ichimura Y, Izumi S, et al. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman\u2019s disease. Histopathology. 2017; doi: 10.1111\/his.13186 .","DOI":"10.1111\/his.13186"},{"issue":"4","key":"8934_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5414\/CN107037","volume":"77","author":"N Jindal","year":"2012","unstructured":"Jindal N, Yadav D, Passero C, Krasinskas A, Craig F, Bastacky S, et al. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. Clin Nephrol. 2012;77(4):321\u20138.","journal-title":"Clin Nephrol"},{"issue":"1","key":"8934_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00795-016-0145-4","volume":"50","author":"A Manabe","year":"2017","unstructured":"Manabe A, Igawa T, Takeuchi M, Gion Y, Yoshino T, Sato Y. Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease. Med Mol Morphol. 2017;50(1):34\u201341. doi: 10.1007\/s00795-016-0145-4 .","journal-title":"Med Mol Morphol"},{"issue":"2","key":"8934_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1172\/jci114749","volume":"86","author":"SJ Brandt","year":"1990","unstructured":"Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman\u2019s disease in mice. J Clin Invest. 1990;86(2):592\u20139. doi: 10.1172\/jci114749 .","journal-title":"J Clin Invest"},{"issue":"1","key":"8934_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.167.1.505","volume":"167","author":"M Schwarz","year":"2001","unstructured":"Schwarz M, Murphy PM. Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol. 2001;167(1):505\u201313.","journal-title":"J Immunol"},{"issue":"3","key":"8934_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/j.sult.2013.12.005","volume":"35","author":"D Bonekamp","year":"2014","unstructured":"Bonekamp D, Hruban RH, Fishman EK. The great mimickers: Castleman disease. Semin Ultrasound CT MR. 2014;35(3):263\u201371. doi: 10.1053\/j.sult.2013.12.005 .","journal-title":"Semin Ultrasound CT MR"},{"issue":"12","key":"8934_CR35","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034","volume":"93","author":"Y Aoki","year":"1999","unstructured":"Aoki Y, Jaffe ES, Chang Y, Jones K, Teruya-Feldstein J, Moore PS, et al. Angiogenesis and hematopoiesis induced by Kaposi\u2019s sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999;93(12):4034\u201343.","journal-title":"Blood"},{"key":"8934_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/jbm.s60514","volume":"7","author":"KL Chan","year":"2016","unstructured":"Chan KL, Lade S, Prince HM, Harrison SJ. Update and new approaches in the treatment of Castleman disease. J Blood Med. 2016;7:145\u201358. doi: 10.2147\/jbm.s60514 .","journal-title":"J Blood Med"},{"issue":"23","key":"8934_CR37","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1200\/jco.2009.27.2377","volume":"28","author":"F Rhee van","year":"2010","unstructured":"van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, et al. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman\u2019s disease. J Clin Oncol. 2010;28(23):3701\u20138. doi: 10.1200\/jco.2009.27.2377 .","journal-title":"J Clin Oncol"},{"issue":"8","key":"8934_CR38","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106(8):2627\u201332. doi: 10.1182\/blood-2004-12-4602 .","journal-title":"Blood"},{"issue":"18","key":"8934_CR39","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2169\/internalmedicine.55.6919","volume":"55","author":"T Ikeura","year":"2016","unstructured":"Ikeura T, Horitani S, Masuda M, Kasai T, Yanagawa M, Miyoshi H, et al. IgG4-related disease involving multiple organs with elevated serum interleukin-6 levels. Intern Med. 2016;55(18):2623\u20138. doi: 10.2169\/internalmedicine.55.6919 .","journal-title":"Intern Med"},{"issue":"7","key":"8934_CR40","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/rheumatology\/kep098","volume":"48","author":"M Yamamoto","year":"2009","unstructured":"Yamamoto M, Takahashi H, Hasebe K, Suzuki C, Naishiro Y, Hayashi T, et al. The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome\u2014expansion of SIPS to the territory of Castleman\u2019s disease. Rheumatology (Oxford). 2009;48(7):860\u20132. doi: 10.1093\/rheumatology\/kep098 .","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8934_CR41","first-page":"1645","volume":"45","author":"M Assmar","year":"2016","unstructured":"Assmar M, Yeganeh S, Mansourghanaei F, Amirmozafari N. Combined evaluation of AFP, CA15-3, CA125, CA19-9, and CEA tumor markers in patients with hepatitis B and C. Iran J Public Health. 2016;45(12):1645\u201351.","journal-title":"Iran J Public Health"},{"issue":"14","key":"8934_CR42","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.18632\/oncotarget.2906","volume":"6","author":"M Zhu","year":"2015","unstructured":"Zhu M, Guo J, Li W, Lu Y, Fu S, Xie X, et al. Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K\/mTOR signaling pathway in liver cells. Oncotarget. 2015;6(14):12196\u2013208. doi: 10.18632\/oncotarget.2906 .","journal-title":"Oncotarget"},{"issue":"4","key":"8934_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ans.13128","volume":"86","author":"Y Berger","year":"2016","unstructured":"Berger Y, Nevler A, Shwaartz C, Lahat E, Zmora O, Gutman M, et al. Elevations of serum CA-125 predict severity of acute appendicitis in males. ANZ J Surg. 2016;86(4):260\u20133. doi: 10.1111\/ans.13128 .","journal-title":"ANZ J Surg"},{"key":"8934_CR44","doi-asserted-by":"publisher","unstructured":"Mizejewski G. Alpha-fetoprotein (AFP) and inflammation: is AFP an acute and\/or chronic phase reactant? J Hematol Thrombo Dis. 2015;3(1):191. doi: 10.4172\/2329-8790.1000191 .","DOI":"10.4172\/2329-8790.1000191"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-017-8934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:21:43Z","timestamp":1602490903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-017-8934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["8934"],"URL":"https:\/\/doi.org\/10.1007\/s12026-017-8934-y","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}